For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.
Scope of the Report:
The global average price of Avian Influenza Vaccines is in the decreasing trend, from 20 K USD/K doses in 2011 to 19.8 USD/K doses in 2015. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Avian Influenza Vaccines includes H5 Avian Influenza Vaccines, H9 Avian Influenza Vaccines and other Avian Influenza Vaccines, and the proportion of H5 Avian Influenza Vaccines in 2015 is about 73%, and the proportion is in decreasing trend from 2011 to 2015.
Avian Influenza Vaccines is widely used in Chicken, Duck & Goose and Other birds. The most proportion of Avian Influenza Vaccines is used in chicken, and the production proportion in 2015 is about 77%.
China region is the largest supplier of Avian Influenza Vaccines, with a production market share nearly 49% in 2015. Asia (Ex. China) is the second largest supplier of Avian Influenza Vaccines, enjoying production market share nearly 23% in 2015.
China is the largest consumption place, with a consumption market share nearly 45% in 2015. Following China, Asia (Ex. China) is the second largest consumption place with the consumption market share of 26%.
Market competition is intense. Merial, QYH Biotech, DHN, HVRI, CEVA, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Avian Influenza Vaccines is expected to grow at a CAGR of roughly 2.5% over the next five years, will reach 120 million US$ in 2024, from 100 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Avian Influenza Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Merial
- CEVA
- Zoetis
- Elanco (Lohmann )
- Merck Animal Health
- Avimex Animal Health
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Type H5
- Type H9
- Other
Market Segment by Applications, can be divided into
- Chicken
- Duck & Goose
- Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Avian Influenza Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Avian Influenza Vaccines, with price, sales, revenue and global market share of Avian Influenza Vaccines in 2017 and 2018.
Chapter 3, the Avian Influenza Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Avian Influenza Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Avian Influenza Vaccines market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Avian Influenza Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.